Meningococcal Vaccines Market Worth $4.92 Billion By 2030
Meningococcal Vaccines Industry Overview The global meningococcal vaccines market size is expected to reach USD 4.92 billion by 2030, registering a CAGR of 6.2%, according to a new report by Grand View Research, Inc. Increasing prevalence of meningitis is one of the major factors attributed to the market growth. For instance, according to ECDC, it was estimated that in 2017, 3,221 confirmed cases were observed in EU member states, wherein 58% cases were found in the U.K., France, Spain, and Germany. Moreover, a high incidence of meningitis disease is found in the “meningitis belt” of sub-Saharan Africa, and approximately 30,000 cases are reported every year in this region. Meningococcal Vaccines Market Segmentation Grand View Research has segmented the meningococcal vaccines market based on type, brand, serotype, age group, sales channel, and region: Based on the Type Insights, the market is segmented into Bivalent, Quadrivalent, Others. The Quad...